| Patents for A61K 38 - Medicinal preparations containing peptides (316,240) |
|---|
| 06/12/2008 | US20080139465 Large Scale Preparation of Alpha-1 Proteinase Inhibitor and Use Thereof |
| 06/12/2008 | US20080139464 Isolated Ny-Eso-1 Peptides Which Bind To Hla Class II Molecules And Uses Thereof |
| 06/12/2008 | US20080139463 Suppresses cell-mediated immune response by preventing production and release of several autocrine T-cell growth factors, including interleukin 2 (IL-2), from activated T cells |
| 06/12/2008 | US20080139462 Treatment of membrane-associated diseases and disorders using lantibiotic containing compositions |
| 06/12/2008 | US20080139461 Containing the sequence RGD for the preparation of appropriately functionalised antagonists of alpha v beta 3 and alpha v beta 5 integrins; treatment of altered angiogenic phenomena or for the preparation of diagnostically useful compounds |
| 06/12/2008 | US20080139460 Binding agents for CD44 glycoproteins and methods of use |
| 06/12/2008 | US20080139459 Conjugates A Polypeptide And A Pentasaccharide |
| 06/12/2008 | US20080139458 Methods of Treatment For Injured or Diseased Joints |
| 06/12/2008 | US20080139457 Therapeutic compositions comprising chorionic gonadotropins and HMG CoA reductase inhibitors |
| 06/12/2008 | US20080139456 Macrocyclic Sh2 Domain Binding Inhibitors |
| 06/12/2008 | US20080139455 (2S,3S,E)-2-amino-14,14-difluoro-3-hydroxytetradec-6-enoic acid; serine palmitoyl transferase ; insulin resistance, pancreatic beta cell apoptosis, obesity, pro-thrombotic conditions, myocardial infarction, hypertension, dyslipidemia |
| 06/12/2008 | US20080139454 Method for stabilizing polypeptides lacking methionine |
| 06/12/2008 | US20080139453 Comprising an emulsifying crosslinked siloxane elastomer, a hydrophobically modified polymeric emulsifier, a solvent for the emulsifying crosslinked siloxane elastomer and water; for moisturizing, protecting and/or treating the skin and/or keratinous fibers; sunscreen |
| 06/12/2008 | US20080139452 Nucleotide sequences coding protein factors for use in identifying modulators for diagnosis, treatment and prevention of cell proliferative, metabolic, inflammatory, nervous system and immune disorders |
| 06/12/2008 | US20080139451 Compositions for Treating Ocular Surface Pathologies |
| 06/12/2008 | US20080139450 Antimicrobial Compositions and Uses Thereof |
| 06/12/2008 | US20080139449 X-Ray Structure of Human Fpps and Use For Selecting Fpps Binding Compounds |
| 06/12/2008 | US20080138896 Methods for Inhibiting Melanocyte Stem Cell Loss |
| 06/12/2008 | US20080138894 Recombinant expression in eukaryotic or mammalian cells using vectors; cleavage and site-directed mutagenesis |
| 06/12/2008 | US20080138791 Compositions and methods for prolonging survival of platelets |
| 06/12/2008 | US20080138440 Methods of diagnosing and alleviating gadolinium toxicity |
| 06/12/2008 | US20080138437 Reduce toxicity while maintaining efficacy; mix with particulate hydroxyapatite as an auxiliary agent; alkylating agent, antimetabolite, an antitumor antibiotic, plant preparation, hormone preparation, immunotherapeutic agent, cisplatin; injection, infusion, oral administration |
| 06/12/2008 | US20080138426 Remedies for sex hormone dependent disease |
| 06/12/2008 | US20080138419 Method for preparing an orally administrable formulation for controlled release |
| 06/12/2008 | US20080138416 Method and systems for using biopolymer-based beads and hydrogels |
| 06/12/2008 | US20080138395 Reduced glutathione or certain thiol derivatives of glutathione in combination with anthocyans or anthocyanidins |
| 06/12/2008 | US20080138393 Water soluble extract of spinach for prevention and repair of DNA damage |
| 06/12/2008 | US20080138380 Use of Dermatan Sulfrates and/or Desulfated Heparins to Treat or Prevent Heparinoid-Induced Autoimmune Responses |
| 06/12/2008 | US20080138364 Injection of botulinum toxin types A, B, C1, D, E, F or G as analgesic for diabetes- or cancer-associated pain not associated with headache or muscle spasm |
| 06/12/2008 | US20080138358 Protective protein comprising protease sequences from newly excysted juveniles for use in vaccination and prevention of parasitic infection of gut tissues |
| 06/12/2008 | US20080138353 Alpha b-chrystallin as a therapy for inflammation |
| 06/12/2008 | US20080138352 Identification and characterization of novel proline racemases and hydroxyproline-2-epimerases, uses thereof, and methods of identifying proline racemases and hydroxyproline-2-epimerases |
| 06/12/2008 | US20080138351 Liposome treatment of viral infections |
| 06/12/2008 | US20080138348 G-protein coupled receptor ligands and methods |
| 06/12/2008 | US20080138347 Dsp-10 dual-specificity phosphatase |
| 06/12/2008 | US20080138346 Antibodies to a chemokine expressed in inflamed adenoid |
| 06/12/2008 | US20080138338 Polypeptide variants |
| 06/12/2008 | US20080138337 Connexin enhances chemotherapy-induced apoptosis in human cancer cells inhibiting tumor cell proliferation |
| 06/12/2008 | US20080138333 Internalizing anti-cd74 antibodies and methods of use |
| 06/12/2008 | US20080138331 Using uterine tumor specific marker as diagnostic tool in detection of urogenital specific cell proliferative disorders |
| 06/12/2008 | US20080138330 Methods and Compositions for Treating Conditions Involving Abnormal Angiogenesis |
| 06/12/2008 | US20080138329 Inhibitors of Dna Methylation in Tumor Cells |
| 06/12/2008 | US20080138328 Novel Use of the Kinases Rsk4 and Pak5 |
| 06/12/2008 | US20080138327 Apparatus for preparing sanitized fluids for preventing bacterial growth on surfaces |
| 06/12/2008 | US20080138326 Administering reduced coenzyme Q; cosmeceuticals, cosmetics, foods |
| 06/12/2008 | US20080138316 Use of a Combination of Cyclosporine and Pegylated Interferon for Treating Hepatitis C (Hcv) |
| 06/12/2008 | US20080138315 Using expression vector comprising UDP-glucuronosyltransferase (UGTIAI) as gene transfer tool in treatment of hyperbilirubinemia |
| 06/12/2008 | US20080138314 Use of il-22 for the treatment of conditions of metabolic disorders |
| 06/12/2008 | US20080138284 Novel Peptides That Promote Lipid Efflux |
| 06/12/2008 | US20080138280 Composition and Methods For Inhibiting Cell Survival |
| 06/12/2008 | US20080138278 Conjugates of rgd peptides and porphyrin or (bacterio) chlorohyll photosynthesizers and their uses |
| 06/12/2008 | US20080138277 Drug delivery of therapeutic agent and carrier comprising targeting moiety that interacts with a target molecule such as chemokines, interferons, interleukins, osteoponting, chaperone proteins, receptors, and cellular adhesion molecules present in atherosclerotic lesions in blood vessels; diagnosis |
| 06/12/2008 | CA2708004A1 Conjoint therapy for treating fibrotic diseases |
| 06/12/2008 | CA2671697A1 Use of il-27 agonists to reduce immune mediated abortion |
| 06/12/2008 | CA2671613A1 Methods of use of trk receptor modulators |
| 06/12/2008 | CA2671492A1 Compositions and methods to treat cancer with cupredoxins and cpg rich dna |
| 06/12/2008 | CA2671447A1 Amphiphilic entity nanoparticles |
| 06/12/2008 | CA2671410A1 Peptide and treatment for hiv-1 infection |
| 06/12/2008 | CA2670950A1 Truncated pth peptides with a cyclic conformation |
| 06/12/2008 | CA2670899A1 Use of hydrolytic and oxidative enzymes to dissolve biofilm in ears |
| 06/12/2008 | CA2670491A1 Inhibitors of protein tyrosine phosphatase for the promotion of physiological cardiac hypertrophy |
| 06/12/2008 | CA2668347A1 Tissue plasminogen activator variant uses |
| 06/12/2008 | CA2643826A1 Compositions and methods for transport of molecules with enhanced release properties across biological barriers |
| 06/11/2008 | EP1930440A1 Bacterial Strains, Genes and Enzymes for Control of Bacterial Diseases by Quenching Quorum-Sensing Signals |
| 06/11/2008 | EP1930439A1 Neurotrophic factors |
| 06/11/2008 | EP1930433A1 T-cell receptor and nucleic acid encoding the receptor |
| 06/11/2008 | EP1930420A1 Isolated nucleic acid molecules encoding a bacterial uracil phosphoribosyl-transferase enzyme, cells transformed therewith and uses thereof |
| 06/11/2008 | EP1930344A1 Polypeptide having anti-angiogenic activity |
| 06/11/2008 | EP1930025A1 ANTIGEN-AND-DRUG VEHICLE WHICH ENABLES THE CHANGEOVER FROM THE SELECTIVE PRODUCTION OF IgA ANTIBODY TO THE PRODUCTION OF BOTH OF IgA AND IgG ANTIBODIES, AND TRANSNASAL/TRANSMUCOSAL VACCINE USING THE VEHICLE |
| 06/11/2008 | EP1930024A2 G-CSF solution formulations having long-term stability |
| 06/11/2008 | EP1930023A2 Erythropoietin ameliorates chemotherapy-induced toxicity in vivo |
| 06/11/2008 | EP1930022A1 Treatment of bladder fibrosis with antibodies against alpha V beta 6 integrin |
| 06/11/2008 | EP1930021A2 Novel amide derivatives as growth hormone secretagogues |
| 06/11/2008 | EP1930017A1 Composition effective for prevention and treatment of adult disease |
| 06/11/2008 | EP1929996A2 Ophthalmic emulsions containing an immunosuppressive agent |
| 06/11/2008 | EP1929860A1 Transgenic avian which has foreign gene containing sequence encoding feline-derived protein and method for production thereof |
| 06/11/2008 | EP1929073A2 Proteinaceous pharmaceuticals and uses thereof |
| 06/11/2008 | EP1929050A2 Compositions and methods using same for the detection of viruses |
| 06/11/2008 | EP1929032A2 Regulation of toll-like receptors on stem cells |
| 06/11/2008 | EP1929005A1 Human coagulation factor vii polypeptides |
| 06/11/2008 | EP1928916A2 Immunomodulatory compositions and uses therefor |
| 06/11/2008 | EP1928906A2 Liquid formulations of pegylated growth hormone |
| 06/11/2008 | EP1928904A2 Method and system for extracting blood-derived growth factors |
| 06/11/2008 | EP1928900A1 Variants of the lantibiotic mersacidin and their use |
| 06/11/2008 | EP1928896A2 Anchoring disruption molecules |
| 06/11/2008 | EP1928551A2 Methods to reduce oxalate concentration by administration of oxalate oxidase crystals |
| 06/11/2008 | EP1928498A2 Methods to treat t-cell disorders using tisf |
| 06/11/2008 | EP1928497A2 Combination therapies for inhibiting integrin-extracellular matrix interactions |
| 06/11/2008 | EP1928496A2 C/clp antagonists and methods of use thereof |
| 06/11/2008 | EP1928494A2 Combination therapy for immunostimulation |
| 06/11/2008 | EP1928491A2 Protein formulation for promoting hard tissue formation |
| 06/11/2008 | EP1928489A2 Analogs of ghrelin |
| 06/11/2008 | EP1928488A1 Oligodendrocyte precursor cell proliferation regulated by prolactin |
| 06/11/2008 | EP1928487A2 A novel peptide involved in energy homeostasis |
| 06/11/2008 | EP1928486A2 Methods for using and identifying modulators of delta-like 4 |
| 06/11/2008 | EP1928485A2 Stable pharmaceutical compositions including motilin-like pepetides |
| 06/11/2008 | EP1928484A2 Methods for treatment of headaches by administration of oxytocin |
| 06/11/2008 | EP1928483A1 Factor h for the treatment of chronic nephropathies and production thereof |
| 06/11/2008 | EP1928397A1 Method for enhancing effects of colorants and conditioners |
| 06/11/2008 | EP1928248A2 Protein kinase modulation by hops and acacia products |